bone sarcoma
bone sarcoma
Explore linked clinical trials. Standard reference: MONDO:002105425 results · Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| LMWH vs Aspirin for VTE Prophylaxis in Orthopaedic Oncology | Embolism and Thrombosis, Hematoma, Hemorrhage, Neoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Connective and Soft Tissue, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Thromboembolism, bone disorder, bone sarcoma, cardiovascular disorder, musculoskeletal system disorder, neoplasm, sarcoma, vascular disorder, venous thromboembolism | Enrolling by invitation | Phase 4 | 2026-10-09 | NCT03244020 | |
| Bridging Adolescent and Young Adult Sarcoma Survivors With Personalized Oncology Exercise Service (AYA-ONE): A Pilot Intervention | Neoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Connective and Soft Tissue, bone disorder, bone sarcoma, musculoskeletal system disorder, neoplasm, sarcoma | Recruiting | Not applicable | 2026-08-26 | NCT07662239 | |
| A First-In-Human Phase 1 Trial of T-Cell Membrane-Anchored Tumor Targeted Il12 (Attil12)- T-Cell Therapy in Subjects With Advanced/Metastatic Soft Tissue and Bone Sarcoma | Neoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Connective and Soft Tissue, bone disorder, bone sarcoma, musculoskeletal system disorder, neoplasm, sarcoma | Active, not recruiting | Phase 1 | 2026-08-18 | NCT05621668 | |
| Evaluation of Tumor Resection Guided by Intraoperative Indocyanine Green Dye Fluorescence Angiography in Patients With Sarcoma | Neoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Connective and Soft Tissue, bone disorder, bone sarcoma, musculoskeletal system disorder, neoplasm, sarcoma | Recruiting | Not stated | 2026-08-04 | NCT06409013 | |
| "Exercise Intervention to Increase Physical Activity in Young Sarcoma Survivors (Sport Ist Herzenssache)" | Neoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Connective and Soft Tissue, bone disorder, bone sarcoma, musculoskeletal system disorder, neoplasm, sarcoma | Not yet recruiting | Not applicable | 2026-07-27 | NCT07729059 | |
| XL092 (Zanzalintinib) for the Treatment of Patients With Metastatic or Unresectable Leiomyosarcoma, Bone Sarcoma or Translocation-associated Soft Tissue Sarcoma | Ewing sarcoma, Neoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Bone Tissue, Neoplasms, Connective and Soft Tissue, bone disorder, bone sarcoma, connective tissue neoplasm, leiomyosarcoma, musculoskeletal system disorder, myomatous neoplasm, neoplasm, osteosarcoma, sarcoma, synovial sarcoma | Recruiting | Phase 2 | 2026-06-18 | NCT06571734 | |
| In Situ Immunomodulation With CDX-301, Radiation Therapy, CDX-1140 and Poly-ICLC in Patients w/ Unresectable and Metastatic Solid Tumors | DNA Virus Infections, Infections, Neoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Bone Tissue, Neoplasms, Connective and Soft Tissue, Neoplasms, Germ Cell and Embryonal, Neoplasms, Nerve Tissue, Skin and Connective Tissue Diseases, Tumor Virus Infections, adenocarcinoma, basal cell carcinoma, basal cell neoplasm, bone disorder, bone sarcoma, breast disorder, breast neoplasm, carcinoma, connective tissue neoplasm, cutaneous neuroendocrine carcinoma, epithelial neoplasm, melanocytic neoplasm, melanoma, metastatic melanoma, musculoskeletal system disorder, neoplasm, neuroendocrine carcinoma, neuroendocrine neoplasm, osteosarcoma, polyomavirus infectious disease, primitive neuroectodermal tumor, sarcoma, skin disorder, skin neoplasm, skin squamous cell carcinoma, viral infectious disease | Active, not recruiting | Phase 1 | 2026-06-18 | NCT04616248 | |
| Preoperative Immunonutrition in Patients With Bone and Soft Tissue Sarcomas | Atrophy, Neoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Connective and Soft Tissue, Neurologic Manifestations, Neuromuscular Manifestations, Nutritional and Metabolic Diseases, Pathologic Processes, Pathological Conditions, Anatomical, Pathological Conditions, Signs and Symptoms, Postoperative Complications, Sarcopenia, Signs and Symptoms, bone disorder, bone sarcoma, muscular atrophy, musculoskeletal system disorder, neoplasm, nervous system disorder, nutritional deficiency disease, nutritional disorder, sarcoma | Recruiting | Not applicable | 2026-05-27 | NCT07609329 | |
| Gemcitabine Plus Ascorbate for Sarcoma in Adults (Pilot) | Neoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Connective and Soft Tissue, bone disorder, bone sarcoma, musculoskeletal system disorder, neoplasm, sarcoma | Active, not recruiting | Early phase 1 | 2026-05-22 | NCT04634227 | |
| LN-145 or LN-145-S1 in Treating Patients With Relapsed or Refractory Ovarian Cancer, Triple Negative Breast Cancer (TNBC), Anaplastic Thyroid Cancer, Osteosarcoma, or Other Bone and Soft Tissue Sarcomas | Adnexal Diseases, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Genital Diseases, Neoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Bone Tissue, Neoplasms, Connective and Soft Tissue, Neoplasms, Fibrous Tissue, Skin and Connective Tissue Diseases, Urogenital Diseases, Urogenital Neoplasms, bone disorder, bone giant cell tumor, bone sarcoma, breast disorder, breast neoplasm, carcinoma, connective tissue neoplasm, dedifferentiated chondrosarcoma, endocrine system disorder, epithelial neoplasm, female reproductive system disorder, female reproductive system neoplasm, giant cell tumor, gonadal disorder, histiocytoma, malignancy in giant cell tumor of bone, malignant endocrine neoplasm, musculoskeletal system disorder, neoplasm, osteosarcoma, ovarian cancer, ovarian carcinosarcoma, ovarian disorder, poorly differentiated thyroid gland carcinoma, sarcoma, skin disorder, thyroid gland squamous cell carcinoma, thyroid gland undifferentiated (anaplastic) carcinoma, triple-negative breast carcinoma, undifferentiated high grade pleomorphic sarcoma of bone, undifferentiated pleomorphic sarcoma | Active, not recruiting | Phase 2 | 2026-05-22 | NCT03449108 | |
| Study Assessing the Effects of Early Psychiatric Referral on Mental Health and Quality of Life in People With Sarcoma | Neoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Connective and Soft Tissue, bone disorder, bone sarcoma, musculoskeletal system disorder, neoplasm, sarcoma | Recruiting | Not applicable | 2026-05-15 | NCT06129903 | |
| Assessment of Healing and Function After Reconstruction Surgery for Bone Sarcomas | Ewing sarcoma, Neoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Bone Tissue, Neoplasms, Connective and Soft Tissue, bone disorder, bone sarcoma, chondrosarcoma, connective tissue neoplasm, musculoskeletal system disorder, neoplasm, osteosarcoma, sarcoma | Recruiting | Not stated | 2026-04-17 | NCT03442465 | |
| Assessment of the Functional Outcome and Quality of Life in Sarcoma Patients | Neoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Connective and Soft Tissue, bone disorder, bone sarcoma, musculoskeletal system disorder, neoplasm, sarcoma | Recruiting | Not applicable | 2026-03-16 | NCT05051059 | |
| Comparing Carbon Ion Therapy, Surgery, and Proton Therapy for Management of Pelvic Sarcomas Involving the Bone | Ewing sarcoma of bone, Neoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Connective and Soft Tissue, Neoplasms, Germ Cell and Embryonal, bone disorder, bone sarcoma, chondrosarcoma, chordoma, connective tissue neoplasm, musculoskeletal system disorder, neoplasm, sarcoma | Recruiting | Not stated | 2026-03-13 | NCT05033288 | |
| Efficacy of Regorafenib Combined With Best Supportive Care as Maintenance Treatment in High Grade Bone Sarcomas Patients | Neoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Bone Tissue, Neoplasms, Connective and Soft Tissue, bone disorder, bone sarcoma, connective tissue neoplasm, musculoskeletal system disorder, neoplasm, osteosarcoma, sarcoma | Recruiting | Phase 2 | 2026-02-17 | NCT04698785 | |
| Efficacy and Safety of Regorafenib as Maintenance Therapy After First-line Treatment in Patients With Bone Sarcomas | Disease Attributes, Disease Progression, Ewing sarcoma, Neoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Bone Tissue, Neoplasms, Connective and Soft Tissue, Neoplasms, Fibrous Tissue, Pathologic Complete Response, Pathologic Processes, Pathological Conditions, Signs and Symptoms, angiosarcoma, bone disorder, bone sarcoma, chondrosarcoma, connective tissue neoplasm, histiocytoma, leiomyosarcoma, musculoskeletal system disorder, myomatous neoplasm, neoplasm, osteosarcoma, sarcoma, undifferentiated pleomorphic sarcoma, vascular cancer | Recruiting | Not applicable | 2026-02-17 | NCT04055220 | |
| GISAR German Interdisciplinary Sarcoma Registry | Neoplasms by Histologic Type, Neoplasms, Bone Tissue, Neoplasms, Connective and Soft Tissue, bone sarcoma, carcinosarcoma, connective tissue neoplasm, mixed neoplasm, neoplasm, osteosarcoma, sarcoma | Recruiting | Not stated | 2026-02-05 | NCT04122872 | |
| Implant-Related Infections in Patients With Skeletal Sarcomas | Infections, Neoplasms by Histologic Type, Neoplasms, Bone Tissue, Neoplasms, Connective and Soft Tissue, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Postoperative Complications, bone sarcoma, connective tissue neoplasm, neoplasm, osteosarcoma, prosthesis-related infectious disease, sarcoma | Enrolling by invitation | Not stated | 2025-12-04 | NCT07264296 | |
| In Vivo Lung Perfusion for Pulmonary Metastases of Sarcoma | Neoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Connective and Soft Tissue, bone disorder, bone sarcoma, musculoskeletal system disorder, neoplasm, sarcoma | Recruiting | Phase 1 | 2025-11-26 | NCT02811523 | |
| Sequential Infusion of CD146-Targeted and HER2-Targeted CAR T Cells in Patients With Advanced Sarcomas | DNA Virus Infections, Ewing sarcoma, Hemic and Lymphatic Diseases, Herpesviridae infectious disease, Infections, Kaposi's sarcoma, Neoplasms by Histologic Type, Neoplasms, Bone Tissue, Neoplasms, Connective and Soft Tissue, bone sarcoma, connective tissue neoplasm, immune system disorder, immunoproliferative disorder, lymphatic system disorder, lymphoma, lymphoproliferative syndrome, neoplasm, osteosarcoma, sarcoma, synovial sarcoma, vascular cancer, viral infectious disease | Recruiting | Phase 1 / Phase 2 | 2025-07-15 | NCT07066982 | |
| Observational Study, for Quality Assessment, of Sarcoma in European and Latin American Multidisciplinary NETWORK | Digestive System Diseases, Digestive System Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Connective and Soft Tissue, bone disorder, bone sarcoma, connective tissue neoplasm, digestive system disorder, digestive system neoplasm, gastrointestinal stromal tumor, musculoskeletal system disorder, neoplasm, sarcoma | Recruiting | Not stated | 2025-03-21 | NCT04181970 | |
| Chemo-immunotherapy in Patients Under 18 Years of Age With Bone and Soft Tissue Sarcomas | Myosarcoma, Neoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Connective and Soft Tissue, Rhabdomyosarcoma, Embryonal, alveolar rhabdomyosarcoma, bone disorder, bone sarcoma, musculoskeletal system disorder, myomatous neoplasm, neoplasm, rhabdomyosarcoma, sarcoma | Recruiting | Phase 3 | 2024-11-01 | NCT06669013 | |
| Phase II Clinical Trial of Chidamide Combined With AK112 for Second-line and Advanced Bone and Soft Tissue Sarcoma | Neoplasms by Histologic Type, Neoplasms, Bone Tissue, Neoplasms, Connective and Soft Tissue, bone sarcoma, connective tissue neoplasm, neoplasm, osteosarcoma, sarcoma | Recruiting | Phase 2 | 2024-10-15 | NCT06637007 | |
| PARP Inhibition, Stereotactic Body Radiotherapy and Immunotherapy for Metastatic or Advanced Sarcoma (PRIMA) | Neoplasms by Histologic Type, Neoplasms, Bone Tissue, Neoplasms, Connective and Soft Tissue, bone sarcoma, connective tissue neoplasm, neoplasm, osteosarcoma, sarcoma | Recruiting | Phase 2 | 2023-10-31 | NCT06074692 | |
| Registry For Children, Adolescents And Adults With Osteosarcoma And Biologically Related Bone Sarcomas | Neoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Bone Tissue, Neoplasms, Connective and Soft Tissue, Neoplasms, Fibrous Tissue, bone angiosarcoma, bone disorder, bone neoplasm, bone sarcoma, chondroblastic osteosarcoma, connective tissue neoplasm, conventional osteosarcoma, extraosseous osteosarcoma, fibrosarcomatous osteosarcoma, high grade surface osteosarcoma, histiocytoma, juxtacortical osteosarcoma, low grade central osteosarcoma, musculoskeletal system disorder, neoplasm, osteoblastic osteosarcoma, osteosarcoma, periosteal osteogenic sarcoma, sarcoma, small cell osteogenic sarcoma, telangiectatic osteogenic sarcoma, undifferentiated pleomorphic sarcoma | Not yet recruiting | Not stated | 2022-08-25 | NCT05515068 |